Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme

Majek, Ondrej; Danes, Jan; Skovajsova, Miroslava; Bartonkova, Helena; Buresova, Lucie; Klimes, Daniel; Brabec, Petr; Kozeny, Pavel; Dusek, Ladislav
January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p288
Academic Journal
Background: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. Methods: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. Results: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. Conclusions: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.


Related Articles

  • Effect of Previous Benign Breast Biopsy on the Interpretive Performance of Subsequent Screening Mammography. Taplin, Stephen H.; Abraham, L.; Geller, B. M.; Yankaskas, B. C.; Buist, D. S. M.; Smith-Bindman, R.; Lehman, C.; Weaver, D.; Carney, P. A.; Barlow, W. E. // JNCI: Journal of the National Cancer Institute;Jul2010, Vol. 102 Issue 14, p1040 

    Background: Most breast biopsies will be negative for cancer. Benign breast biopsy can cause changes in the breast tissue, but whether such changes affect the interpretive performance of future screening mammography is not known.

  • Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices. LeBlanc, Erin S.; Viscoli, Catherine M.; Henrich, Janet B. // Journal of Women's Health & Gender-Based Medicine;Jul/Aug99, Vol. 8 Issue 6, p815 

    Previous studies have reported that breast cancer patients who used estrogen replacement therapy (ERT) have more favorable tumor characteristics and decreased mortality compared with nonusers. However, these findings may be due partly to increased medical surveillance in ERT users and detection...

  • Digital mammography screening: how many breast cancers are additionally detected by bilateral ultrasound examination during assessment? Weigel, Stefanie; Biesheuvel, Cornelis; Berkemeyer, Shoma; Kugel, Harald; Heindel, Walter // European Radiology;Mar2013, Vol. 23 Issue 3, p684 

    Objective: To assess the positive predictive values of incremental breast cancer detection (PPV1) in relation to the mammographic breast density and of performed biopsies (PPV3) resulting from supplemental bilateral physician-performed whole-breast ultrasound (US) at recall of a population-based...

  • Specificity of screening in United Kingdom trial of early detection of breast cancer.  // BMJ: British Medical Journal (International Edition);2/8/92, Vol. 304 Issue 6823, p346 

    Examines the specificity of screening for breast cancer by clinical examination with or without mammography in Great Britain. Ratio of benign to malignant biopsy specimens after the first screen; Estimation of the extra breast biopsies from a population screening programme; Identification of...

  • Breast cancer screening. Newson, Louise // GP: General Practitioner;4/27/2007, p41 

    The article presents information on breast cancer screening. Mammography is currently offered to all women aged 50-70 years to reduce breast cancer mortality in Great Britain. Overdetection of breast cancer may cause harm to a patient. Most women are receiving inadequate information on the...

  • Does the English Breast Screening Programmes information leaflet improve womens knowledge about mammography screening? A before and after questionnaire survey. Premila Webster; Joan Austoker // Journal of Public Health;Jun2007, Vol. 29 Issue 2, p173 

    : Objectives To explore whether the English Breast Screening Programmes leaflet improved womens knowledge of breast cancer screening. : Design Before and after postal questionnaire survey. : Participants A random sample of 100 women aged between 49 and 64 years registered with GPs in...

  • Biennial mammographic screening elevated false-positive risk.  // Hem/Onc Today;10/25/2013, Vol. 14 Issue 20, p54 

    The article presents the results of a retrospective review as of late October 2013, which showed one of five females aged 50-69 years participating in the Norwegian Breast Cancer Screening Program were seen to have false-positive screening result during the 10 biennial screening examinations.

  • ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer. Bernstein, J. L.; Bernstein, L.; Thompson, W. D.; Lynch, C. F.; Malone, K. E.; Teitelbaum, S. L.; Olsen, J. H.; Anton-Culver, H.; Boice Jr., J. D.; Rosenstein, B. S.; Børresen-Dale, A-L; Gatti, R. A.; Concannon, P.; Haile, R. W.; Boice, J D; Børresen-Dale, A-L; WECARE Study Collaborative Group // British Journal of Cancer;10/20/2003, Vol. 89 Issue 8, p1513 

    Recent reports suggest that two ATM gene mutations, 7271T>G and IVS10-6T>G, are associated with a high risk of breast cancer among multiple-case families. To assess the importance of these two mutations in another 'high-risk' group, young women (under age 51) with multiple primaries, we screened...

  • Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. Duffy, Stephen W.; Tabar, Laszlo; Olsen, Anne Helene; Vitak, Bedrich; Allgood, Prue C.; Chen, Tony H. H.; Yen, Amy M. F.; Smith, Robert A. // Journal of Medical Screening;Mar2010, Vol. 17 Issue 1, p25 

    Objectives To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years. Setting The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics